# FDA recall D-1470-2016

> **Teva North America** · Class II · drug recall initiated 2016-06-24.

## Product

Amoxicillin for Oral Suspension USP, 400 mg/ 5 mL, 50 mL bottle, Rx only, Manufactured In Canada by: Teva Canada Limited, Toronto, Canada, NDC 0093-4161-76

## Reason for recall

Superpotent drug: Out of specification test result for assay during stability testing.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1470-2016
- **Recalling firm:** Teva North America
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2016-06-24
- **Report date:** 2016-08-31
- **Termination date:** 2017-02-07

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Horsham, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1470-2016

## Citation

> AI Analytics. FDA recall D-1470-2016. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-1470-2016. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*